The store will not work correctly when cookies are disabled.
1-Ethyl-5-(5-furan-2-yl-penta-2,4-dienylidene)-2-thioxodihydro-pyrimidine-4,6-dione
ID: ALA4177462
PubChem CID: 145972953
Max Phase: Preclinical
Molecular Formula: C15H14N2O3S
Molecular Weight: 302.36
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCN1C(=O)/C(=C\C=C\C=C\c2ccco2)C(=O)NC1=S
Standard InChI: InChI=1S/C15H14N2O3S/c1-2-17-14(19)12(13(18)16-15(17)21)9-5-3-4-7-11-8-6-10-20-11/h3-10H,2H2,1H3,(H,16,18,21)/b5-3+,7-4+,12-9-
Standard InChI Key: RWOPIXPNFHZSRA-LYDVKKHVSA-N
Molfile:
RDKit 2D
21 22 0 0 0 0 0 0 0 0999 V2000
10.7978 -11.1626 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5122 -10.7501 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.2267 -11.1626 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2267 -11.9876 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5122 -12.4001 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7978 -11.9876 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.9412 -10.7501 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.5122 -13.2251 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.0833 -10.7501 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
12.9412 -12.4001 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9412 -13.2251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6557 -13.6376 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6557 -14.4626 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3701 -14.8751 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7027 -16.1850 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.3701 -15.7001 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0376 -16.1850 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7826 -16.9696 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9576 -16.9696 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0833 -12.4001 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3688 -11.9876 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
1 6 1 0
3 7 2 0
5 8 2 0
1 9 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
15 19 1 0
14 16 1 0
4 10 2 0
20 21 1 0
6 20 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 302.36 | Molecular Weight (Monoisotopic): 302.0725 | AlogP: 2.04 | #Rotatable Bonds: 4 |
Polar Surface Area: 62.55 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 7.70 | CX Basic pKa: ┄ | CX LogP: 2.37 | CX LogD: 2.19 |
Aromatic Rings: 1 | Heavy Atoms: 21 | QED Weighted: 0.40 | Np Likeness Score: -1.05 |
References
1. Ramisetti SR, Pandey MK, Lee SY, Karelia D, Narayan S, Amin S, Sharma AK.. (2018) Design and synthesis of novel thiobarbituric acid derivatives targeting both wild-type and BRAF-mutated melanoma cells., 143 [PMID:29133035] [10.1016/j.ejmech.2017.11.006] |